Please enable JS

DISCOVER

REGISTRIES

REGISTRY OF PRACTICES, OBSERVATIONAL STUDIES, DATABASE

The collection and analysis of standardised data from professional practices are particularly widespread within professional organisations, learned societies and networks. The organisation and content of these collections can take various forms: registry, observational studies, database. Integrated for the purpose of improving practices, these programmes constitute a CPD method. (Continuing Professional Development)

corner top

HEALTH
PROFESSIONALS
AND PROFESSIONAL STRUCTURES

Telemedicine Technologies supports HCPs (Healthcare Professionals) and PSs (Professional Structures), with the technical implementation of these databases, as well as monitoring indicators and feedback to the actors of this registry (HCPs, PSs).

corner bottom

The registry incorporating the improvement process is set up and managed by a professional structure, made up of peers, this structure is responsible for:
• the theme (professional practices);
• the design of the approach;
• the quality of the data collected;
• the analysis and use of these practices.

The indicators put in place, targeted at key elements of practice and easy to collect, make it possible to objectify the quality of care and to monitor the improvement initiatives undertaken. Thus, in Data Visualisation, we can restore these indicators, by adding a comparative component. For example, each PDS can compare his practice with those of all the PDSs in his organisation or with the average practice of all the PDSs in his speciality, and more generally, with the whole practice of the PDS of a registry in a European registry.

EUROPEAN
REGISTRIES

Telemedicine Technologies also participates in the technical support of structures wishing to create European registries based on national registries existing in different countries, to create a common register with a minimum of information that is specific to each country and making it possible to centralise information from these different countries in a database, independent of each national registry and supplied from these national registries by interoperability with the desired update frequency.

Our Data Services structure can also offer the setup of European databases in CDISC format, to allow and facilitate exchanges with regulatory agencies.

DOWNLOAD OUR FLYER
ON STATE-OF-THE-ART DATA SERVICES

A LEADING POSITION AND
AN INTERNATIONAL DEPLOYMENT

64 +

countries
involved

20 000 +

investigational
Centres

2 million +

patients
in database

50 000 +

users
worlwide

telemedicine technologies earth

LATEST NEWSOUR NEWS >

telemedecine technologies news

TELEMEDICINE TECHNOLOGIES acquires the start-up CTMA and its software suite CT-SCOUT and ToTem4me, to strengthen and accelerate patient recruitment in clinical trials

January 19, 2023

Telemedicine Technologies continues to acquire companies that provide innovative solutions and services to its customers. The acquisition of the CTMA (Clinical Trials Mobile Application) software suite enables Telemedicine Technologies to offer investigating centres assistance to accelerate patient recruitment in clinical trials, and to ensure their commitments to sponsors. The digital transformation of healthcare institutions is […]

READ MORE
telemedecine technologies news

Trialbee inks deal with Acclinate in push for trial diversity 

December 19, 2022

Fierce Biotech Trialbee, a patient enrollment company, inked a partnership deal with Acclinate in a push to accelerate wider patient diversity in clinical trials. Under the partnership, Sweden-based Trialbee will get access to Acclinate’s NOWINCLUDED offering that engages diverse populations on health-related issues, the company said in a Dec. 13 press release. Founded in 2020, Birmingham, Alabama-based […]

READ MORE
telemedecine technologies news

Regulators Speak About Decentralized Clinical Trials

December 19, 2022

Applied Clinical Trials The concept of decentralized clinical trials (DCT) is still in its infancy in the industry, although the pandemic has facilitated its adoption. FDA has issued a guidance document for operating under the pandemic, as did EMA which outline several characteristics of DCTs, including remote study visits, clinical outcomes assessments (COAs), monitoring and inspections, to name […]

READ MORE